Global Sleep Apnea Devices Market valued at $5.5 bn in 2021 is set to witness a growth of 7% by 2026

BRUSSELS - June 28, 2022 - PRLog -- Obstructive sleep apnea (OSA) is the most common form of sleep-disordered breathing (SDB). It is a partial or complete collapse of the upper airway caused by the relaxation of the muscles controlling the soft palate and tongue. The prevalence of OSA has been increasing steadily, and as per estimates, it affects ~3% to 20% of the general population.

Technological Advancements is driving the Sleep Apnea Devices Market

The sleep apnea devices market is a technology-driven market and is marked by constant product enhancements and market innovations. For instance,

• In October, 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms.
• In August 2021, Resmed, launched AirSense 11, the company's next-generation PAP (positive airway pressure) device.

"A home sleep apnea test (HSAT) is financially more friendly. It costs ~ $200 to $600, which is relatively less than $800 to $3,000 for an overnight visit to a sleep lab. Also, insurers are increasingly requiring HSAT as a first step before paying for an in-lab sleep apnea test."-Director, Leading Manufacturer, United States

Growth Strategies Adopted by Market Players to Establish Their Foothold

Players operating in the market adopt both organic and inorganic growth strategies such as new product launches, and partnerships to garner market share. For instance,

• In December 2021, ZOLL® Medical Corporation, completed the acquisition of Itamar™ Medical Ltd., a medical device and digital health company that provides at-home testing for sleep apnea.
• In February 2021, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea launched a new oral appliance - O2Vent Optima.

The global sleep apnea devices market is a lucrative market which is set to witness a decent growth in the upcoming years due to technological advancements in diagnostic and therapeutic sleep apnea devices, increasing awareness campaigns.

The sleep apnea devices market is marked by the presence of key players such as ResMed, Philips Respironics, Fisher & Paykel Healthcare, SomnoMed, Itamar Medical, Inspire Medical Systems, Compumedics, Oventus Medical, Natus Medical, Drive DeVilbiss Healthcare, Whole You, BMC Medical, among others.

Get Customized Research Report on Sleep Apnea Devices Market @ https://meditechinsights.com/sleep-apnea-devices-market/